Metabolic consequences of sleep-disordered breathing

ILAR Journal

Volumn 50, Issue 3, 2009, Pages 289-306

  Jun, Jonathan ^a   Polotsky, Vsevolod Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Intermittent hypoxia; Metabolic syndrome; Metabolism; Obesity; Risk factor; Rodent model; Sleep apnea

Indexed keywords

ANIMALIA; RODENTIA;

ANIMAL; ANOXIA; DYSLIPIDEMIA; HUMAN; LIVER DISEASE; METABOLIC DISORDER; MOUSE; OBESITY; PATHOPHYSIOLOGY; RAT; REVIEW; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION;

ANIMALS; ANOXIA; DYSLIPIDEMIAS; HUMANS; LIVER DISEASES; METABOLIC DISEASES; MICE; OBESITY; RATS; SLEEP APNEA SYNDROMES; SLEEP DEPRIVATION;

EID: 69849097508     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.50.3.289     Document Type: Article

References (238)

1. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. 2005. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 129:113-121.
2. Akashiba T, Akahoshi T, Kawahara S, Majima T, Horie T. 2005. Effects of longterm nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med 44:899-900.
3. Al Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. 2002. Snoring as a risk factor for type II diabetes mellitus: A prospective study. Am J Epidemiol 155:387-393.
4. Angulo P. 2002. Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231.
5. Ayas NT, Brown R, Shea SA. 2000. Hypercapnia can induce arousal from sleep in the absence of altered respiratory mechanoreception. Am J Respir Crit Care Med 162:1004-1008.
6. Aydogan M, Toprak D, Hatun S, Yuksel A, Gokalp AS. 2007. The effect of recurrent tonsillitis and adenotonsillectomy on growth in childhood. Int J Pediatr Otorhinolaryngol 71:1737-1742.
7. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. 2005. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165:447-452.
8. Baekey DM, Feng P, Decker MJ, Strohl KP. 2009. Breathing and sleep: Measurement methods, genetic influences, and developmental impacts. ILAR J 50:248-261.
9. Baker-Herman TL, Mitchell GS. 2008. Determinants of frequency longterm facilitation following acute intermittent hypoxia in vagotomized rats. Respir Physiol Neurobiol 162:8-17.
10. Barceló A, Barbé F, Llompart E, Mayoralas LR, Ladaria A, Bosch M, Agustí AG. 2004. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117:118-121.
11. Barceló A, Barbé F, de la Peña M, Martinez P, Soriano JB, Piérola J, Agustí AG. 2008. Insulin resistance and daytime sleepiness in patients with sleep apnea. Thorax 63:946-950.
12. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. 2000. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112-117.
13. Berthon-Jones M, Sullivan CE. 1984. Ventilation and arousal responses to hypercapnia in normal sleeping humans. J Appl Physiol 57:59-67.
14. Boyer SJ, Blume FD. 1984. Weight loss and changes in body composition at high altitude. J Appl Physiol 57:1580-1585.
15. Braun B. 2008. Effects of high altitude on substrate use and metabolic economy: Cause and effect? Med Sci Sports Exerc 40:1495-1500.
16. Brebbia DR, Altshuler KZ. 1965. Oxygen consumption rate and electroencephalographic stage of sleep. Science 150:1621-1623.
17. Brooks B, Cistulli PA, Borkman M, Ross G, McGhee S, Grunstein RR, Sullivan CE, Yue DK. 1994. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79:1681-1685.
18. Brooks D, Horner RL, Kimoff RJ, Kozar LF, Render-Teixeira CL, Phillipson EA. 1997a. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 155:1609-1617.
19. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. 1997b. Obstructive sleep apnea as a cause of systemic hypertension: Evidence from a canine model [see comments]. J Clin Invest 99:106-109.
20. Browning JD, Horton JD. 2004. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152.
21. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. 2004. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:1387-1395.
22. Buckley TM, Schatzberg AF. 2005. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106-3114.
23. Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, Ciovica R, Tiwari U, Ferrel L, Pabst M, Bass NM, Merriman RB. 2008. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology 47:1916-1923.
24. Carneiro G, Togeiro SM, Hayashi LF, Ribeiro-Filho FF, Ribeiro AB, Tufik S, Zanella MT. 2008. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am J Physiol Endocrinol Metab 295:E380-E384.
25. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. 1996. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance [see comments]. Lancet 348:159-161.
26. Chen B, Lam KS, Wang Y, Wu D, Lam MC, Shen J, Wong L, Hoo RL, Zhang J, Xu A. 2006. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341:549-556.
27. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. 2005. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172:915-920.
28. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M. 2000. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-567.
29. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H, Muro S, Hattori N, Matsumoto H, Niimi A, Chiba T, Nakao K, Mishima M, Ohi M, Nakamura T. 2003. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 114: 370-376.
30. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakao K, Ohi M. 1999. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712.
31. Clark JM. 2006. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40:S5-S10.
32. Clark JM, Diehl AM. 2003. Nonalcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis. JAMA 289:3000-3004.
33. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240-243.
34. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans [see comments]. N Engl J Med 334:292-295.
35. Consolazio CF, Johnson HL, Krzywicki HJ, Daws TA. 1972. Metabolic aspects of acute altitude exposure (4,300 meters) in adequately nourished humans. Am J Clin Nutr 25:23-29.
36. Cummins EP, Comerford KM, Scholz C, Bruning U, Taylor CT. 2007. Hypoxic regulation of NF-kappaB signaling. Methods Enzymol 435:479-492.
37. Daltro C, Gregorio PB, Alves E, Abreu M, Bomfim D, Chicourel MH, Araujo L, Cotrim HP. 2007. Prevalence and severity of sleep apnea in a group of morbidly obese patients. Obes Surg 17:809-814.
38. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397.
39. Davies RJ, Turner R, Crosby J, Stradling JR. 1994. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: Their comparison with matched controls and response to treatment. J Sleep Res 3:180-185.
40. Day CP, James OF. 1998. Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845.
41. DeFronzo RA, Tobin JD, Andres R. 1979. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223.
42. Deibert DC, DeFronzo RA. 1980. Epinephrine-induced insulin resistance in man. J Clin Invest 65:717-721.
43. Delarue J, Magnan C. 2007. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10:142-148.
44. Dematteis M, Godin-Ribuot D, Arnaud C, Ribuot C, Stanke-Labesque F, Pépin JL, Lévy P. 2009. Cardiovascular consequences of sleep-disordered breathing: Contribution of animal models to understanding the human disease. ILAR J 50:262-281.
45. Dick TE, Hsieh YH, Wang N, Prabhakar N. 2007. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92:87-97.
46. Diehl AM. 2005. Lessons from animal models of NASH. Hepatol Res 33: 138-144.
47. Dimsdale JE, Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler MG. 1997. Sympathetic nervous system alterations in sleep apnea: The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 111:639-642.
48. Dixon JB, Bhathal PS, O'Brien PE. 2001. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91-100.
49. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. 2008. Effects of CPAP on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134:686-692.
50. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. 2005. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613-618.
51. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi-Filho G. 2007. Effects of CPAP on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706-712.
52. Dutta A, Ray K, Singh VK, Vats P, Singh SN, Singh SB. 2008. L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats. Exp Physiol 93:1139-1146.
53. Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G. 2000. The role of habitual snoring and obesity in the development of diabetes: A 10-year follow-up study in a male population. J Intern Med 248:13-20.
54. Farre R, Montserrat JM, Navajas D. 2008. Morbidity due to obstructive sleep apnea: Insights from animal models. Curr Opin Pulm Med 14:530-536.
55. Fletcher EC. 2003. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26:15-19.
56. Fletcher EC, Bao G. 1996a. Effect of episodic eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats. J Appl Physiol 81:2088-2094.
57. Fletcher EC, Bao G. 1996b. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19:S210-S212.
58. Fletcher EC, Lesske J, Culman J, Miller CC, Unger T. 1992a. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20:612-619.
59. Fletcher EC, Lesske J, Qian W, Miller CC, Unger T. 1992b. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats [see comments]. Hypertension 19:555-561.
60. Fletcher EC, Bao G, Miller CC III. 1995. Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J Appl Physiol 78:1516-1521.
61. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. 1992. Nocturnal cortisol release in relation to sleep structure. Sleep 15:21-27.
62. Fontvieille AM, Rising R, Spraul M, Larson DE, Ravussin E. 1994. Relationship between sleep stages and metabolic rate in humans. Am J Physiol 267:E732-E737.
63. Franken P, Malafosse A, Tafti M. 1999. Genetic determinants of sleep regulation in inbred mice. Sleep 22:155-169.
64. Fraser G, Trinder J, Colrain IM, Montgomery I. 1989. Effect of sleep and circadian cycle on sleep period energy expenditure. J Appl Physiol 66:830-836.
65. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395:763-770.
66. Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, Larranaga E, Moreno-Otero R. 2000. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716-724.
67. Gautier H. 1996. Interactions among metabolic rate, hypoxia, and control of breathing. J Appl Physiol 81:521-527.
68. Gilmartin GS, Tamisier R, Curley M, Weiss JW. 2008. Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol 295:H778-H785.
69. Gozal D, Capdevila OS, Kheirandish-Gozal L. 2008. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 177:1142-1149.
70. Grahnstedt S, Ursin R. 1985. Platform sleep deprivation affects deep slow wave sleep in addition to REM sleep. Behav Brain Res 18:233-239.
71. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. 2006. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596.
72. Greenberg HE, Sica A, Batson D, Scharf SM. 1999. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86:298-305.
73. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. 2006. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21:1-6.
74. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. 1996. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 42:558-563.
75. Gutierrez-Juarez R, Pocai A, Mulas C, Ono H, Bhanot S, Monia BP, Rossetti L. 2006. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 116:1686-1695.
76. Guzy RD, Schumacker PT. 2006. Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807-819.
77. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT. 2005. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:401-408.
78. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546.
79. Haller H. 1977. [Epidemiology and associated risk factors of hyperlipoproteinemia]. Z Gesamte Inn Med 32:124-128.
80. Hamad N, Travis SP. 2006. Weight loss at high altitude: Pathophysiology and practical implications. Eur J Gastroenterol Hepatol 18:5-10.
81. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. 2007. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13:1579-1584.
82. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH. 2004. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162.
83. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22.
84. Hilakivi I, Peder M, Elomaa E, Johansson G. 1984. Validation of the cuff pedestal technique for rapid eye movement sleep (REMS) deprivation by electrophysiological recordings. Physiol Behav 32:945-947.
85. Hilden M, Christoffersen P, Juhl E, Dalgaard JB. 1977. Liver histology in a "normal" population: Examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 12:593-597.
86. Hoffmann, A Baltimore D. 2006. Circuitry of nuclear factor kappaB signaling. Immunol Rev 210:171-186.
87. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP. 2007. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175:851-857.
88. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. 2000. Serum leptin and vascular risk factors in obstructive sleep apnea [see comments]. Chest 118:580-586.
89. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. 2002. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676.
90. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K. 2008. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoidactivating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol 285:10-18.
91. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
92. Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T, Zhang BB. 2005. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115:1030-1038.
93. Jouet P, Sabate JM, Maillard D, Msika S, Mechler C, Ledoux S, Harnois F, Coffin B. 2007. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: A prospective study. Obes Surg 17:478-485.
94. Jun J, Polotsky VY. 2007. Sleep-disordered breathing and metabolic effects: Evidence from animal models. Sleep Medicine Clinics 2:263-277.
95. Jun JC, Savransky V, Nanayakkara A, Bevans S, Li J, Smith PL, Polotsky VY. 2008. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 295:R1274-R1281.
96. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. 2007. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 41:918-921.
97. Kalra SP. 2001. Circumventing leptin resistance for weight control. Proc Natl Acad Sci U S A 98:4279-4281.
98. Kellogg RH. 1978. "La pression barometrique": Paul Bert's hypoxia theory and its critics. Respir Physiol 34:1-28.
99. Kheirandish-Gozal L, Sans CO, Kheirandish E, Gozal D. 2008. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 133:92-99.
100. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. 2001. Prevention of fatinduced insulin resistance by salicylate. J Clin Invest 108:437-446.
101. Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK. 2006. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177:7211-7224.
102. Knutson KL, Van CE. 2008. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 1129:287-304.
103. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. 2006. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20:2242-2250.
104. Korner PI, White SW. 1966. Circulatory control in hypoxia by the sympathetic nerves and adrenal medulla. J Physiol 184:272-290.
105. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, Prabhakar NR. 2006. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575:229-239.
106. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP. 1996. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 94:273-278.
107. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, Despres JP. 1998. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279:1955-1961.
108. LaRosa JC. 2003. Reduction of serum LDL-C levels: A relationship to clinical benefits. Am J Cardiovasc Drugs 3:271-281.
109. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. 1997. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504 (Pt 1):241-249.
110. Lavie L. 2003. Obstructive sleep apnoea syndrome: An oxidative stress disorder. Sleep Med Rev 7:35-51.
111. Lavie L, Vishnevsky A, Lavie P. 2004. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123-128.
112. Law MR, Wald NJ, Rudnicka AR. 2003. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 326:1423.
113. Lee EJ, Woodske ME, Zou B, O'Donnell CP. 2008. A mouse model of intermittent hypoxia that produces clinically relevant decreases in arterial PO2 and oxyhemoglobin desaturation. Am J Resp Crit Care Med 177:A269.
114. Lesske J, Fletcher EC, Bao G, Unger T. 1997. Hypertension caused by chronic intermittent hypoxia: Influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593-1603.
115. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O'Donnell CP, Polotsky VY. 2005a. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99:1643-1648.
116. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, Polotsky VY. 2005b. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97:698-706.
117. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY. 2006. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25:450-457.
118. Li J, Nanayakkara A, Jun J, Savransky V, Polotsky VY. 2007a. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia. Physiol Genomics 31:273-280.
119. Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY. 2007b. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102:557-563.
120. Lin CC, Chang KC, Lee KS. 2002. Effects of treatment by laser-assisted uvuloplasty on sleep energy expenditure in obstructive sleep apnea patients. Metabolism 51:622-627.
121. Loube DI, Loube AA, Erman MK. 1997. Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 97:896-897.
122. Louhija A. 1969. Hypertriglyceridemia in rats at simulated high altitudes. Experientia 25:248-249.
123. MacDonald ML, Singaraja RR, Bissada N, Ruddle P, Watts R, Karasinska JM, Gibson WT, Fievet C, Vance JE, Staels B, Hayden MR. 2008. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J Lipid Res 49:217-229.
124. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289.
125. Magalang UJ, Cruff JP, Rajappan R, Hunter MG, Patel T, Marsh CB, Raman SV, Parinandi NL. 2009. Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin Endocrinol Diabetes 117:129-134.
126. Major GC, Series F, Tremblay A. 2007. Does the energy expenditure status in obstructive sleep apnea favour a positive energy balance? Clin Invest Med 30:E262-E268.
127. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. 2001. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 50:1844-1850.
128. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917-923.
129. Marin JM, Carrizo SJ, Vicente E, Agusti AG. 2005. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365:1046-1053.
130. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. 2008. Sleep apnea as an independent risk factor for all-cause mortality: The Busselton Health Study. Sleep 31:1079-1085.
131. Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec D, Degott C, Erlinger S, Benhamou JP, Bernuau J. 1995. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 109:1682-1684.
132. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. 2004. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29-33.
133. McArdle N, Hillman D, Beilin L, Watts G. 2007. Metabolic risk factors for vascular disease in obstructive sleep apnea: A matched controlled study. Am J Respir Crit Care Med 175:190-195.
134. McCullough AJ. 2006. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:S17-S29.
135. Mendelson WB, Guthrie RD, Frederick G, Wyatt RJ. 1974. The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav 2:553-556.
136. Meston N, Davies RJ, Mullins R, Jenkinson C, Wass JA, Stradling JR. 2003. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 254:447-454.
137. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M. 2005. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625-630.
138. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. 2001. Sleepdisordered breathing and coronary artery disease: Long-term prognosis. Am J Respir Crit Care Med 164:1910-1913.
139. Moromisato DY, Moromisato MY, Brasel JA, Cooper DM. 1999. Effect of growth hormone therapy in mitigating hypoxia-induced and food restriction-induced growth retardation in the newborn rat. Crit Care Med 27:2234-2238.
140. Multiple Risk Factor Intervention Trial Research Group. 1982. Multiple risk factor intervention trial: Risk factor changes and mortality results. JAMA 248:1465-1477.
141. Nanduri J, Yuan G, Kumar GK, Semenza GL, Prabhakar NR. 2008. Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 164: 277-281.
142. NIH [National Institutes of Health]. 2002. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH National Cholesterol Education Program (NCEP)/ATP III. Bethesda: National Institutes of Health.
143. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. 1988. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 27:142-149.
144. Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, Loredo JS, Lavine JE, Dimsdale JE. 2008. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 31:121-126.
145. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y. 1999. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-14.
146. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. 2003. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179-184.
147. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, Gokhan N. 2003. Lipid peroxidation and osmotic fragility of red blood cells in sleepapnea patients. Clin Chim Acta 332:83-88.
148. Peng Y, Kline DD, Dick TE, Prabhakar NR. 2001. Chronic intermittent hypoxia enhances carotid body chemoreceptor response to low oxygen. Adv Exp Med Biol 499:33-38.
149. Peng YJ, Overholt JL, Kline D, Kumar GK, Prabhakar NR. 2003. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: Implications for recurrent apneas. Proc Natl Acad Sci U S A 100:10073-10078.
150. Peng YJ, Rennison J, Prabhakar NR. 2004. Intermittent hypoxia augments carotid body and ventilatory response to hypoxia in neonatal rat pups. J Appl Physiol 97:2020-2025.
151. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. 2006. Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577:705-716.
152. Peppard PE, Young T, Palta M, Skatrud J. 2000. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384.
153. Perry JC, D'Almeida V, Souza FG, Schoorlemmer GH, Colombari E, Tufik S. 2006. Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats. Respir Physiol Neurobiol 156:250-258.
154. Phillips BG, Hisel TM, Kato M, Pesek CA, Dyken ME, Narkiewicz K, Somers VK. 1999. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17:1297-1300.
155. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. 2000. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:H234-H237.
156. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell CP. 2003. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253-264.
157. Polotsky VY, Rubin AE, Balbir A, Dean T, Smith PL, Schwartz AR, O'Donnell CP. 2006. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med 7:7-16.
158. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizer MA, Clark JM, Torbenson MS, Schwartz AR. 2009. Obstructive sleep apnea, insulin resistance and steatohepatitis in severe obesity. Am J Respir Crit Care Med 179:228-234.
159. Porte D Jr. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest 46:86-94.
160. Prabhakar NR, Kumar GK. 2004. Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 385:217-221.
161. Prabhakar NR, Kumar GK, Nanduri J, Semenza GL. 2007. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 9:1397-1403.
162. Punjabi NM, Beamer BA. 2009. Alterations in glucose disposal in sleepdisordered breathing. Am J Respir Crit Care Med 179:235-240.
163. Punjabi NM, Polotsky VY. 2005. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99:1998-2007.
164. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. 2002. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682.
165. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. 2004. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 160:521-530.
166. Ramanathan L, Gozal D, Siegel JM. 2005. Antioxidant responses to chronic hypoxia in the rat cerebellum and pons. J Neurochem 93:47-52.
167. Reaven GM. 1988. Banting lecture: Role of insulin resistance in human disease. Diabetes 37:1595-1607.
168. Redenius R, Murphy C, O'Neill E, Al-Hamwi M, Zallek SN. 2008. Does CPAP lead to change in BMI? J Clin Sleep Med 4:205-209.
169. Reeves SR, Gozal E, Guo SZ, Sachleben LR Jr, Brittian KR, Lipton AJ, Gozal D. 2003. Effect of long-term intermittent and sustained hypoxia on hypoxic ventilatory and metabolic responses in the adult rat. J Appl Physiol 95:1767-1774.
170. Reeves SR, Mitchell GS, Gozal D. 2006. Early postnatal chronic intermittent hypoxia modifies hypoxic respiratory responses and long-term phrenic facilitation in adult rats. Am J Physiol Regul Integr Comp Physiol 290:R1664-R1671.
171. Reichmuth KJ, Austin D, Skatrud JB, Young T. 2005. Association of sleep apnea and type II diabetes: A population-based study. Am J Respir Crit Care Med 172:1590-1595.
172. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. 2005. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294:326-333.
173. Rizza RA, Cryer PE, Haymond MW, Gerich JE. 1980. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism 29:1155-1163.
174. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. 2004. Circulating cardiovascular risk factors in obstructive sleep apnoea: Data from randomised controlled trials. Thorax 59:777-782.
175. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. 2004. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380-385. Ryan CF, Love LL, Buckley PA. 1995. Energy expenditure in obstructive sleep apnea. Sleep 18:180-187.
176. Ryan S, Taylor CT, McNicholas WT. 2005. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667.
177. Ryan S, Taylor CT, McNicholas WT. 2006. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174:824-830.
178. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT. 2007. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509-514.
179. Saibara T, Nozaki Y, Nemoto Y, Ono M, Onishi S. 2002. Low socioeconomic status and coronary artery disease. Lancet 359:980.
180. Saini J, Krieger J, Brandenberger G, Wittersheim G, Simon C, Follenius M. 1993. Continuous positive airway pressure treatment: Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25:375-381.
181. Sampath H, Ntambi JM. 2006. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferatoractivated receptor-alpha: Independent and interactive roles in the regulation of lipid metabolism. Curr Opin Clin Nutr Metab Care 9:84-88.
182. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. 2002. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 359:1740-1745.
183. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, Polotsky VY. 2007a. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293:G871-G877.
184. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY. 2007b. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175:1290-1297.
185. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY. 2007c. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45:1007-1013.
186. Savransky V, Jun J, Li J, Nanayakkara A, Fonti S, Moser AB, Steele KE, Schweitzer MA, Patil SP, Bhanot S, Schwartz AR, Polotsky VY. 2008. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res 103:1173-1180.
187. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. 2002. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829-839.
188. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F. 2000. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570.
189. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte DJ. 1996. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 2:589-593.
190. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, Arbeit JM 2008. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111:3343-3354.
191. Selmi C, Montano N, Furlan R, Keen CL, Gershwin ME. 2007. Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med (Maywood) 232:1409-1413.
192. Semenza GL. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167-171.
193. Sen R, Baltimore D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
194. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF, O'Connor GT, Boland LL, Schwartz JE, Samet JM. 2001. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25.
195. Sharma SD, Raghuraman G, Lee MS, Prabhakar NR, Kumar GK. 2009. Intermittent hypoxia activates peptidylglycine α-amidating monooxygenase in rat brainstem via reactive oxygen species-mediated proteolytic processing. J Appl Physiol 106:12-19.
196. Siques P, Brito J, Leon-Velarde F, Barrios L, De La Cruz JJ, Lopez V, Herruzo R. 2007. Hematological and lipid profile changes in sea-level natives after exposure to 3550-m altitude for 8 months. High Alt Med Biol 8:286-295.
197. Somers VK, Mark AL, Abboud FM. 1988. Sympathetic activation by hypoxia and hypercapnia: Implications for sleep apnea. Clin Exp Hypertens [A] 10 Suppl 1:413-422.
198. Somers VK, Dyken ME, Clary MP, Abboud FM. 1995. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904.
199. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. 2000. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284:311-318.
200. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P, Bouros D. 2007. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132:843-851.
201. Stenlof K, Grunstein R, Hedner J, Sjostrom L. 1996. Energy expenditure in obstructive sleep apnea: Effects of treatment with continuous positive airway pressure. Am J Physiol 271:E1036-E1043.
202. Stoohs RA, Facchini F, Guilleminault C. 1996. Insulin resistance and sleepdisordered breathing in healthy humans. Am J Respir Crit Care Med 154:170-174.
203. Svatikova A, Wolk R, Wang HH, Otto ME, Bybee KA, Singh RJ, Somers VK. 2004. Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol Regul Integr Comp Physiol 287:R284-R287.
204. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK. 2005. Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:2435-2439.
205. Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR, O'Donnell CP. 2001. A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91:2758-2766.
206. Tanné F, Gagnadoux F, Chazouillères O, Fleury B, Wendum D, Lasnier E, Lebeau B, Poupon R, Serfaty L. 2005. Chronic liver injury during obstructive sleep apnea. Hepatology 41:1290-1296.
207. Tasali E, Leproult R, Ehrmann DA, Van Cauter E. 2008. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 105:1044-1049.
208. Tatsumi K, Saibara T. 2005. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 33:100-104.
209. Tauman R, O'Brien LM, Ivanenko A, Gozal D. 2005. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 116:e66-e73.
210. Trakada G, Gogos C, Tsiamita M, Siagris D, Goumas P, Spiropoulos K. 2004. A case of ischemic hepatitis. Sleep Breath 8:155-159.
211. Traviss KA, Barr SI, Fleming JA, Ryan CF. 2002. Lifestyle-related weight gain in obese men with newly diagnosed obstructive sleep apnea. J Am Diet Assoc 102:703-706.
212. Tschop M, Morrison KM. 2001. Weight loss at high altitude. Adv Exp Med Biol 502:237-247.
213. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. 2008. Increased risk of stroke in patients with coronary artery disease and sleep apnea: A 10-year follow-up. Circulation 118:955-960.
214. Van CE, Latta F, Nedeltcheva A, Spiegel K, Leproult R, Vandenbril C, Weiss R, Mockel J, Legros JJ, Copinschi G. 2004. Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 14(Suppl A):S10-S17.
215. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. 1994. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705-1711.
216. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. 2000. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hyper-cytokinemia [see comments]. J Clin Endocrinol Metab 85:1151-1158.
217. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bentley CM, Bixler EO, Sarrigiannidis A, Basta M, Chrousos GP. 2007. Hypothalamic-pituitaryadrenal axis activity in obese men with and without sleep apnea: Effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 92:4199-4207.
218. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A, Condliffe AM, Cowburn AS, Johnson N, Chilvers ER. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-kappaB activity. J Exp Med 201:105-115.
219. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxiainducible factor 1. J Biol Chem 270:1230-1237.
220. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92:5510-5514.
221. Wanless IR, Shiota K. 2004. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: A four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 24:99-106.
222. Waters K, Gozal D. 2004. Developmental and metabolic implications of the hypoxic ventilatory response. Paediatr Respir Rev 5:173-181.
223. Weaver JU. 2008. Classical endocrine diseases causing obesity. Front Horm Res 36:212-228.
224. Webb P, Hiestand M. 1975. Sleep metabolism and age. J Appl Physiol 38:257-262.
225. Weinberg JM, Venkatachalam MA, Roeser NF, Nissim I. 2000. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci U S A 97:2826-2831.
226. Whitten BK, Burlington RF, Posiviata MA, Sidel CM, Beecher GR. 1970. Amino acid catabolism in environmental extremes: Effect of high altitude and calories. Am J Physiol 218:1346-1350.
227. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, Luo C, Kheirandish L, Gozal D, Liu R. 2004. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126:313-323.
228. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. 2005. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034-2041.
229. Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashina A. 2006. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189:198-205.
230. Yamauchi M, Kimura H. 2008. Oxidative stress in obstructive sleep apnea: Putative pathways to the cardiovascular complications. Antioxid Redox Signal 10:755-768.
231. Yokoe T, Alonso LC, Romano LC, Rosa TC, O'Doherty RM, Garcia-Ocana A, Minoguchi K, O'Donnell CP. 2008. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586:899-911.
232. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235.
233. Young T, Peppard PE, Gottlieb DJ. 2002. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 165:1217-1239.
234. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM. 2008. Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071-1078.
235. Yuen KC, Dunger DB. 2007. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Diabetes Obes Metab 9:11-22.
236. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC. 2005. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172:921-929.
237. Zhang YS, Du JZ. 2000. The response of growth hormone and prolactin of rats to hypoxia. Neurosci Lett 279:137-140.
238. Zhou D, Xue J, Chen J, Morcillo P, Lambert JD, White KP, Haddad GG. 2007. Experimental selection for Drosophila survival in extremely low O2 environment. PLoS ONE 2:e490.